EPB41L4A and breast carcinoma: Xu et al. [154] have demonstrated that overexpression of EPB41L4A-AS2 inhibits tumor cell growth in renal-, lung-, and breast cancer cell lines, suggesting that it might act as a tumor suppressor by mediating cell proliferation.